Exact Sciences (EXAS), a provider of cancer screening and diagnostic tests, raised revenue estimates for its fourth quarter on Monday. EXAS stock soared on the news. X The company expects revenue in t...
Tag: EXAS
EXAS Stock Soars And GH Stock Crashes: Battle Of The Colon Cancer Tests Heats Up
Guardant Health (GH) unveiled pivotal results for its colon cancer-detecting blood test that lagged rival Exact Sciences (EXAS) — leading GH stock to crash Friday. Meanwhile, EXAS stock skyrocketed. X...
EXAS Stock Surges After Exact Sciences Raises Guidance On Massive Quarterly Beat
Exact Sciences (EXAS) massively beat third-quarter expectations Thursday and raised its full-year outlook — and EXAS stock jumped. X During the September quarter, Exact Sciences brought in $523.1 mill...
Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales
Text size Illumina turned in stronger financial results than expected. Dreamstime The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetic...